MTOR and viral infectious disease: The second major type of pathways modulated by methotrexate treatment were related to the adaptive immune response, such as B cell receptor signaling, sphingolipid signaling pathway and mTOR signaling pathways, resulting in activation of B cells and T cells to counter viral infection (Figure 5B).